Cabometyx (cabozantinib tablets) — Cigna

Initial criteria

• Patient age ≥ 12 years
• Patient has differentiated thyroid carcinoma (e.g., papillary, follicular, or oncocytic type)
• Patient is refractory to radioactive iodine therapy
• Patient has tried Lenvima (lenvatinib) or sorafenib

Approval duration

1 year